CORINNE HERTSEL: Open Payments
NPI 1164064119 · SYRACUSE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$199 in 11 payments from 9 companies in 2025. Trend: 2023 $234 · 2024 $222 · 2025 $199
Food & beverage: $199
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| ABBVIE INC. | 2 | $33 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Dexcom, Inc. | 1 | $15 |
Products named: CAPLYTA, JARDIANCE, INSPIRE, QULIPTA, XIFAXAN, GEMTESA, REXULTI, Dexcom G6 Transmitter.
Industry payments across IN — which companies pay providers there.
